search
Back to results

Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)

Primary Purpose

Renal Calculi, Ureteral Calculi

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Burst Wave Lithotripsy
Sponsored by
University of Washington
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Renal Calculi

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Individuals presenting with at least one kidney stone apparent on CT
  • Individuals scheduled for clinical stone removal via ureteroscopy (URS)

Exclusion Criteria:

  • Individuals under 18 years of age
  • Individuals belonging to a vulnerable group (pregnant, mentally disabled, prisoner, etc.)
  • Individuals with uncorrected bleeding disorders or coagulopathies
  • Individuals taking a clinically significant anticoagulant dose at the time of the procedure
  • Individuals with a calcified abdominal aortic aneurysm or calcified renal artery aneurysm
  • Individuals with a solitary kidney
  • Individuals with a comorbidity risks which, at the discretion of the physician, would make the patient a poor candidate for the BWL procedure

Sites / Locations

  • IU Health North Hospital
  • University of Washington Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Treatment Group

Arm Description

Subjects in this arm receive the 10-minute burst wave lithotripsy intervention dose during their standard-of-care lithotripsy procedure.

Outcomes

Primary Outcome Measures

Safety - Area of Tissue Injury
The primary safety endpoint is the area of hemorrhage observed through direct visualization with the ureteroscope.
Effectiveness - Volume of Fragments < 2 mm
The primary effectiveness endpoint is the volume fraction of stone fragments less than 2 mm relative to the original stone volume.

Secondary Outcome Measures

Safety - Adverse Event Assessment
The secondary safety outcome is the documented occurrence of all adverse events and comparison of the incidence (rate of occurrence) to the adverse events typically associated with shock wave lithotripsy (SWL) and URS
Effectiveness - Time to Full Comminution
projected time to full comminution defined as the time at which no fragments would be ≤ 2 mm

Full Information

First Posted
March 9, 2019
Last Updated
March 29, 2023
Sponsor
University of Washington
Collaborators
Indiana University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
search

1. Study Identification

Unique Protocol Identification Number
NCT03873259
Brief Title
Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)
Official Title
Burst Wave Lithotripsy (BWL) for the Comminution of Urinary Tract Stones: Intraoperative Evaluation of Safety and Effectiveness
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
August 8, 2019 (Actual)
Primary Completion Date
April 15, 2024 (Anticipated)
Study Completion Date
April 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Washington
Collaborators
Indiana University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Burst Wave Lithotripsy (BWL) is a novel method of urinary stone fragmentation that uses multi-cycle bursts of low amplitude ultrasound to induce stone fracture. This is in contrast to traditional extracorporeal shock wave lithotripsy (SWL), which employs a brief single compression/tensile cycle of high amplitude (shock) waves to achieve stone fracture. This is a single-arm feasibility study to test the ability of BWL to comminute (fragment) stones in humans.
Detailed Description
This is a two-center, single-arm, feasibility study. The two centers are located within the US and include: University of Washington (UW) School of Medicine and Indiana University (IU) Health Urology Clinic. The investigative study will be performed in the operating room prior to a standard-of-care (SoC) ureteroscopic (URS) laser lithotripsy procedure. The subject will already be under anesthesia. Stones will be limited to ≤ 12 mm. The study has one (treatment) arm and is approved to enroll up to 40 subjects (with the intent to treat 20 subjects). All subjects will be treated with the same output parameters for up to a maximum of 10 minutes per stone. The output parameters are nominally defined as: 350 kil0Hertz (kHz) acoustic frequency 7 MegaPascals (MPa) peak negative pressure 20 cycle pulse duration 17 Hz pulse repetition frequency A maximum of 3 stones can be treated per subject. Safety will be monitored by visual observation of the tissue with an ureteroscopic camera, the self-reported occurrences of adverse events, and occurrences of unplanned emergency department or clinic visits. Fragmentation will be measured by visual observation with an ureteroscopic camera and direct measure of stones removed by basket after the procedure.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Renal Calculi, Ureteral Calculi

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Masking Description
Some outcomes assessors will be blinded to the treatment conditions. This will include review of video data for tissue injury.
Allocation
N/A
Enrollment
40 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Treatment Group
Arm Type
Experimental
Arm Description
Subjects in this arm receive the 10-minute burst wave lithotripsy intervention dose during their standard-of-care lithotripsy procedure.
Intervention Type
Device
Intervention Name(s)
Burst Wave Lithotripsy
Intervention Description
Fragment upper urinary tract stones
Primary Outcome Measure Information:
Title
Safety - Area of Tissue Injury
Description
The primary safety endpoint is the area of hemorrhage observed through direct visualization with the ureteroscope.
Time Frame
Day 0 - the day of the experimental procedure immediately following the acoustic procedure.
Title
Effectiveness - Volume of Fragments < 2 mm
Description
The primary effectiveness endpoint is the volume fraction of stone fragments less than 2 mm relative to the original stone volume.
Time Frame
Day 0 - the day of the experimental procedure immediately following the acoustic procedure.
Secondary Outcome Measure Information:
Title
Safety - Adverse Event Assessment
Description
The secondary safety outcome is the documented occurrence of all adverse events and comparison of the incidence (rate of occurrence) to the adverse events typically associated with shock wave lithotripsy (SWL) and URS
Time Frame
out to 120 days post-procedure
Title
Effectiveness - Time to Full Comminution
Description
projected time to full comminution defined as the time at which no fragments would be ≤ 2 mm
Time Frame
Day 0 - the day of the experimental procedure immediately following the acoustic procedure.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Individuals presenting with at least one kidney stone apparent on CT Individuals scheduled for clinical stone removal via ureteroscopy (URS) Exclusion Criteria: Individuals under 18 years of age Individuals belonging to a vulnerable group (pregnant, mentally disabled, prisoner, etc.) Individuals with uncorrected bleeding disorders or coagulopathies Individuals taking a clinically significant anticoagulant dose at the time of the procedure Individuals with a calcified abdominal aortic aneurysm or calcified renal artery aneurysm Individuals with a solitary kidney Individuals with a comorbidity risks which, at the discretion of the physician, would make the patient a poor candidate for the BWL procedure
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Michael R Bailey, PhD, MS
Organizational Affiliation
University of Washington
Official's Role
Principal Investigator
Facility Information:
Facility Name
IU Health North Hospital
City
Carmel
State/Province
Indiana
ZIP/Postal Code
46032
Country
United States
Facility Name
University of Washington Medical Center
City
Seattle
State/Province
Washington
ZIP/Postal Code
98195
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28521550
Citation
May PC, Kreider W, Maxwell AD, Wang YN, Cunitz BW, Blomgren PM, Johnson CD, Park JSH, Bailey MR, Lee D, Harper JD, Sorensen MD. Detection and Evaluation of Renal Injury in Burst Wave Lithotripsy Using Ultrasound and Magnetic Resonance Imaging. J Endourol. 2017 Aug;31(8):786-792. doi: 10.1089/end.2017.0202. Epub 2017 Jun 16.
Results Reference
background
PubMed Identifier
25111910
Citation
Maxwell AD, Cunitz BW, Kreider W, Sapozhnikov OA, Hsi RS, Harper JD, Bailey MR, Sorensen MD. Fragmentation of urinary calculi in vitro by burst wave lithotripsy. J Urol. 2015 Jan;193(1):338-44. doi: 10.1016/j.juro.2014.08.009. Epub 2014 Aug 9.
Results Reference
background
PubMed Identifier
35229652
Citation
Bailey MR, Maxwell AD, Cao S, Ramesh S, Liu Z, Williams JC, Thiel J, Dunmire B, Colonius T, Kuznetsova E, Kreider W, Sorensen MD, Lingeman JE, Sapozhnikov OA. Improving Burst Wave Lithotripsy Effectiveness for Small Stones and Fragments by Increasing Frequency: Theoretical Modeling and Ex Vivo Study. J Endourol. 2022 Jul;36(7):996-1003. doi: 10.1089/end.2021.0714. Epub 2022 Jun 22.
Results Reference
derived
PubMed Identifier
32940089
Citation
Harper JD, Metzler I, Hall MK, Chen TT, Maxwell AD, Cunitz BW, Dunmire B, Thiel J, Williams JC, Bailey MR, Sorensen MD. First In-Human Burst Wave Lithotripsy for Kidney Stone Comminution: Initial Two Case Studies. J Endourol. 2021 Apr;35(4):506-511. doi: 10.1089/end.2020.0725. Epub 2020 Nov 5.
Results Reference
derived
Links:
URL
http://www.apl.washington.edu/project/project.php?id=bwl
Description
Sponsor Website

Learn more about this trial

Intraoperative Assessment of of Burst Wave Lithotripsy (BWL)

We'll reach out to this number within 24 hrs